Hong Kong-listed equities are showing stark earnings divergences as the 2026 reporting season unfolds. According to fund managers involved in Southbound trading, globally positioned biotechnology firms are delivering outsized profit growth, while traditional cyclical sectors face continued demand pressures.

BeiGene

BeiGene (6160.HK) is riding a wave of strong earnings momentum. The company reported a first-half net income of RMB 3.27B in 2026, up an explosive 627.1% year-over-year. Second-quarter global revenue reached USD 1.705B. The firm also announced a clinical collaboration and regional licensing agreement with Revolution Medicines in August to develop RAS(ON) inhibitors in Asia. Analysts noted the deal further validates the company's commercialization capabilities on the global stage.

ZhongAn Online

ZhongAn Online (6060.HK) is sustaining its underwriting profitability trend. The company posted total premium income of RMB 16.66B for the first half of 2025, up 9.3% year-over-year, with net profit reaching RMB 668M. According to people familiar with the matter, the insurtech firm is seeking to unlock value through spin-offs, as its AI subsidiary ZhongAn Tech and insurtech platform Nova have both submitted secondary IPO applications to the Hong Kong stock exchange, a move expected to alleviate cash flow pressures.

WH Group

As the world's largest pork producer, WH Group (0288.HK) is navigating a string of valuation adjustments from Wall Street. Institutions including Morgan Stanley lowered their price targets in late July, though they maintained overweight ratings. Despite near-term earnings concerns, BlackRock increased its long position to 6.17% in early August, signaling that long-term capital still favors the defensive nature of the company's integrated supply chain across the U.S., China, and Europe.

West China Cement

West China Cement (2233.HK) issued a stark profit warning, estimating that net profit for the first half of 2026 will plummet by 45% to 50%, landing between RMB 374M and RMB 412M. Management attributed the decline to falling average selling prices and sales volumes in the Chinese market. However, shares rebounded following the announcement, as market participants bet that earnings growth from its operations in Africa and Uzbekistan could eventually offset domestic weakness.

Morimatsu International

Morimatsu International (2722.HK) is accelerating its global supply chain footprint in the pressure equipment and digitalized factory sectors. The company is targeting branch expansions across seven countries, including Malaysia and Singapore. Its Malaysian facility recently completed the first delivery of modular equipment for power battery raw materials and signed a green energy project in South America, signaling a structural pivot toward the renewable energy track, according to industry analysts.

Fuyao Glass

Fuyao Glass (3606.HK) continues to dominate the automotive glass and accessories supply chain. Commanding over 60% of China's passenger vehicle OEM market and roughly 35% globally, the company is positioned to benefit from the ongoing restructuring of global auto supply chains and rising EV penetration. While recent financial updates are sparse, institutional investors are leaning toward the stock as a core high-yield defensive asset amid macroeconomic uncertainty.

Tigermed

As a leading clinical Contract Research Organization (CRO), Tigermed (3347.HK) is maintaining its full-lifecycle service coverage across the pharmaceutical R&D market. With global biotech financing conditions showing marginal signs of improvement in 2026, the company is expecting a mild recovery in clinical trial orders, heavily relying on its execution capabilities in Multi-Regional Clinical Trials (MRCT) as a primary growth anchor.

China Water Affairs

China Water Affairs (2302.HK) is exhibiting characteristics typical of public utilities in a volatile market. As a water supply and wastewater treatment operator, the firm relies on stable concession rights for recurring cash flows. Analysts covering the sector point out that such utility stocks, offering cash flow certainty and potential dividend yields, are increasingly drawing attention from risk-averse funds amidst broader economic challenges.

Kingsoft Cloud

Kingsoft Cloud (6680.HK) is attempting to carve out a differentiated space in the cloud infrastructure market as demand for underlying computing power broadens. Facing intense price wars from top-tier internet giants, the company is allocating more resources toward vertical industry solutions and AI-driven computing services. The market is closely watching its upcoming earnings for any signs of meaningful margin recovery.

TCL Electronics

TCL Electronics (2577.HK) is pushing forward with its global brand strategy and high-end display upgrades amid a cyclical softening in consumer electronics demand. The company is relying on its market share in Mini LED TVs to offset cost pressures from traditional panel price fluctuations. Supply chain sources indicate that its shipment guidance for the second half of the year will serve as a direct bellwether for the upcoming holiday retail season.

Overall, large and mid-cap equities in Hong Kong are undergoing a brutal, fundamentals-driven divergence. Hedge fund managers note that Southbound and foreign capital allocations have completely detached from broad macroeconomic bets, instead strictly anchoring to realized earnings growth or deep economic moats in overseas manufacturing. As the earnings season deepens, this profit-driven rerating is expected to accelerate.

This article does not constitute investment advice.